|
|
HTG Molecular Diagnostics
|
| General Information |
| Business: |
We are a commercial stage company that developed and markets a novel technology platform to facilitate the routine use of complex molecular profiling. Our HTG Edge automated platform can quickly, robustly and simultaneously profile thousands of clinically relevant molecular targets from samples a fraction of the size required by current technologies. Our objective is to establish the HTG Edge platform as a standard in molecular profiling and make this capability accessible to all molecular labs from research to clinic. We believe that our target customers desire high quality molecular profiling information in a multiplexed panel format from increasingly smaller samples, with the ability to do this locally to minimize turnaround time and cost. The HTG Edge platform was designed to meet these needs and is empowering pathologists, clinicians and molecular labs to directly control the molecular profiling of patient samples. Our platform’s capabilities are also enabling biopharmaceutical companies and research centers to better leverage the power of molecular profiling in their preclinical and clinical applications. |
|
| Industry: |
LABORATORY ANALYTICAL INSTRUMENTS |
|
| Employees: |
77 |
Founded: |
1997 |
|
| Contact Information |
| Address: |
3430 E. Global Loop, Tucson, AZ 85706, US |
|
|
|
|
|
|
|
| Financial Information |
| |
| Revenues: |
$ 3.3 mil (last 12 months) |
|
| Net Income: |
$ -17.6 mil (last 12 months) |
|
| IPO Profile |
|
|
|
|
